Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Weak Stock
217.2300 2.05 (0.95%)
NSE Jan 13, 2026 13:00 PM
Volume: 7,773
 

217.23
0.95%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 19% YoY to | 209 crore (I-direct estimate: | 242 crore). Export formulations declined 11% YoY to | 86 crore (I-direct estimate: | 95 crore) and domestic formulations declined 30% to | 100 crore (I-direct estimate: | 121 crore) EBITDA margins fell 1580 bps YoY to 0.6% (I-direct estimate of 11%) mainly due to higher employee and other expenditure. EBITDA declined 97% YoY to | 1.3 crore (I-direct estimate: | 27 crore)...
Indoco Remedies has lost -33.73% in the last 1 Year
More from Indoco Remedies Ltd.
Recommended